DAFTAR PUSTAKA

Abraham, R.R., 2013. Drug Related Problems and Reactive Pharmacist

Interventions for Inpatients Receiving Cardiovascular Drugs. International
Journal of Basic Medical Sciences and Pharmacy (IJBMSP), 3: 42–48.

Ahmed, M.I., Ekundayo, O.J., Mujib, M., Campbell, R.C., Sanders, P.W., Pitt, B.,
dkk., 2010. Mild Hyperkalemia and Outcomes in Chronic Heart failure: A
propensity matched study. International Journal of Cardiology, 144: 383–
388.

Berger, T.G., 2012. Dermatologic Disorders, dalam: Papadakis, M., McPhee, S.J.,
Rabow, M.W. (Eds.), CURRENT Medical Diagnosis and Treatment 2013.
McGraw-Hill Medical, New York; London.

Bezverhni, Z., Chapichadze, Z., Cavaco, A., Han, D.G., Geurts, M., Grintsova, O.,
dkk., 2012. Pharmaceutical Care Policies and Practices for a Safer, More
Responsible and Cost-Effective Health System. European Directorate for
the Quality of Medicines & HealthCare (EDQM) Council of Europe,
France.

Blix, H.S., 2007. 'Drug-Related Problems in Hospitalised Patients'. University of

Oslo.

Brown, N.J. dan Vaughan, D.E., 1998. Angiotensin-Converting Enzyme

Inhibitors. Circulation, 97: 1411–1420.

Bytzer, P., 2002. H2 Receptor Antagonists and Prokinetics in Dyspepsia: a

Critical Review. Gut, 50: iv58–iv62.

Calhoun, D.A., Jones, D., Textor, S., Goff, D.C., Murphy, T.P., Toto, R.D., dkk.,
2008. Resistant Hypertension: Diagnosis, Evaluation, and Treatment A
Scientific Statement From the American Heart Association Professional
Education Committee of the Council for High Blood Pressure Research.
Circulation, 117: e510–e526.

Cho, K.C., 2012. Electrolyte and Acid-Base Disorders, dalam: Papadakis, M.,
McPhee, S.J., Rabow, M.W. (Eds.), CURRENT Medical Diagnosis and
Treatment 2013. McGraw-Hill Medical, New York; London.

Cipolle, R.J., Strand, L., dan Morley, P.C., 2004. Pharmaceutical Care Practice:
The Clinician’s Guide, Second Edition: The Clinician’s Guide. McGraw-
Hill Companies,Incorporated.

86
Dahlan, M.S., 2013. Statistik untuk Kedokteran dan Kesehatan, 6th ed, 1. Penerbit
Epidemiologi Indonesia, Jakarta.

Damayanti, A., 2009. 'Kajian Drug Related Problems (DRPs) Pada Terapi Pasien
Congestive Heart Failure (CHF) Di Rumkital Dr. Ramelan Surabaya'.
Universitas Gadjah Mada.

Dávalos, A., Castillo, J., Álvarez-Sabín, J., Secades, J.J., Mercadal, J., López, S.,
dkk., 2002. Oral Citicoline in Acute Ischemic Stroke An Individual Patient
Data Pooling Analysis of Clinical Trials. Stroke, 33: 2850–2857.

Delima, Mihardja, L., dan Siswoyo, H., 2009. Prevalensi dan Faktor Determinan
Penyakit Jantung di Indonesia. Puslitbang Biomedis dan Farrnasi, 37: 142
– 159.

DEPKES, 2006. Pharmaceutical Care Untuk Pasien Penyakit Jantung Koroner :

Fokus Sindrom Koroner Akut. Direktorat Bina Farmasi Komunitas dan
Klinik-Ditjen Bina Kefarmasian dan Alat Kesehatan, Jakarta.

Dewi, P.K., 2007. 'Perbedaan Komorbid Gagal Jantung Kongestif Pada Usia
Lanjut Dengan Usia Dewasa Di RS Dr. Kariadi Periode Januari-Desember
2006'. Universitas Diponegoro.

Garcia-Tsao, G., Lim, J.K., Lim, J., dan Members of Veterans Affairs Hepatitis C
Resource Center Program, 2009. Management and Treatment of Patients
with Cirrhosis and Portal Hypertension: Recommendations from the
Department of Veterans Affairs Hepatitis C Resource Center Program and
the National Hepatitis C Program. The American Journal of
Gastroenterology, 104: 1802–1829.

Gillespie, S. dan Bamford, K., 2007. Medical Microbiology and Infection at a

Glance, 3rd ed. John Wiley & Sons.

Hadiatussalamah, 2013. 'Identifikasi Drug Related Problems (DRPs) Pada Pasien

Dengan Diagnosis Congestive Heart Failure Di Instalasi Rawat Inap
Rumah Sakit Umum Pusat Dr. Mohammad Hoesin Palembang Tahun
2012'. Universitas Gadjah Mada.

Hajjar, E.R., Cafiero, A.C., dan Hanlon, J.T., 2007. Polypharmacy in elderly
patients. The American Journal of Geriatric Pharmacotherapy, 5: 345–
351.

Hanlon, J.T., Lindblad, C.I., Hajjar, E.R., dan McCarthy, T.C., 2003. Update on
drug-related problems in the elderly. The American Journal of Geriatric
Pharmacotherapy, 1: 38–43.

87
Havranek, E.P., Thomas, I., Smith, W.B., Ponce, G.A., Bilsker, M., Munger,
M.A., dkk., 1999. Dose-Related Beneficial Long-Term Hemodynamic and
Clinical Efficacy of Irbesartan in Heart Failure. Journal of the American
College of Cardiology, 33: 1174–1181.

Huri, H.Z., Hui Xin, C., dan Sulaiman, C.Z., 2014. Drug-Related Problems in
Patients with Benign Prostatic Hyperplasia: a cross sectional retrospective
study. PloS One, 9: e86215.

Jauch, E.C., Saver, J.L., Adams, H.P., Bruno, A., Connors, J.J. (Buddy),
Demaerschalk, B.M., dkk., 2013. Guidelines for the Early Management of
Patients With Acute Ischemic Stroke A Guideline for Healthcare
Professionals From the American Heart Association/American Stroke
Association. Stroke, 44: 870–947.

Kjeldsen, K., 2010. Hypokalemia and sudden Cardiac Death. Experimental &
Clinical Cardiology, 15: e96–e99.

Lacy, C.F., 2009. Drug Information Handbook: A Comprehensive Resource for

All Clinicians and Healthcare Professionals. Lexi-Comp.

LaPointe, N.M.A. dan Jollis, J.G., 2003. Medication Errors in Hospitalized

Cardiovascular Patients. Archives of Internal Medicine, 163: 1461–1466.

Mandell, L.A., Wunderink, R.G., Anzueto, A., Bartlett, J.G., Campbell, G.D.,
Dean, N.C., dkk., 2007. Infectious Diseases Society of America/American
Thoracic Society Consensus Guidelines on the Management of
Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases:
An Official Publication of the Infectious Diseases Society of America, 44
Suppl 2: S27–72.

Mann, D.L., 2010. Heart Failure and Cor Pulmonale, dalam: Loscalzo, J. (Ed.),
Harrison’s Cardiovascular Medicine. McGraw Hill Professional, hal.
178–197.

Massie, B.M., Carson, P.E., McMurray, J.J., Komajda, M., McKelvie, R., Zile,
M.R., dkk., 2008. Irbesartan in Patients with Heart Failure and Preserved
Ejection Fraction. New England Journal of Medicine, 359: 2456–2467.

McMurray, J.J.V., Adamopoulos, S., Anker, S.D., Auricchio, A., Böhm, M.,
Dickstein, K., dkk., 2012. ESC Guidelines for the diagnosis and treatment
of acute and chronic heart failure 2012: The Task Force for the Diagnosis
and Treatment of Acute and Chronic Heart Failure 2012 of the European
Society of Cardiology. Developed in collaboration with the Heart Failure
Association (HFA) of the ESC. European Heart Journal, 33: 1787–1847.

88
McPhee, S.J. dan Hammer, G.D., 2009. Pathophysiology of Disease An
Introduction to Clinical Medicine, Sixth Edition. McGraw-Hill Education.

McQuaid, K.R., 2013. Gastrointestinal Disorders, dalam: Quinn, G., Gleason, N.,
Papadakis, M., McPhee, S.J. (Eds.), CURRENT Medical Diagnosis and
Treatment Study Guide. McGraw Hill Professional, hal. 564–566.

Moura, C., Acurcio, F., dan Belo, N., 2009. Drug-Drug Interactions Associated
with Length of Stay and Cost of Hospitalization. J Pharm Pharmaceut Sci,
12(3): 266 – 272.

Naranjo, C.A., Busto, U., Sellers, E.M., Sandor, P., Ruiz, I., Roberts, E.A., dkk.,
1981. A method for estimating the probability of adverse drug reactions.
Clinical Pharmacology & Therapeutics, 30: 239–245.

Parham, W.A., Mehdirad, A.A., Biermann, K.M., dan Fredman, C.S., 2006.
Hyperkalemia Revisited. Texas Heart Institute Journal, 33: 40–47.

Parker, R.B., Rodger, J.E., dan Cavallari, L.H., 2008. Heart Failure, dalam:
DiPiro, J., Talbert, R., Yee, G., Matzke, G., Wells, B., Posey, L.M. (Eds.),
Pharmacotherapy: A Pathophysiologic Approach. Mcgraw-hill.

PERDOSSI, 2011. Guideline Stroke Tahun 2011. Pokdi Stroke Perhimpunan

Dokter Spesialis Saraf Indonesia, 1–132.

Rector, T.S., Carson, P.E., Anand, I.S., McMurray, J.J., Zile, M.R., McKelvie,
R.S., dkk., 2012. Assessment of Long-Term Effects of Irbesartan on Heart
Failure With Preserved Ejection Fraction as Measured by the Minnesota
Living With Heart Failure Questionnaire in the Irbesartan in Heart Failure
With Preserved Systolic Function (I-PRESERVE) Trial. Circulation:
Heart Failure, 5: 217–225.

Schwinghammer, T.L., 2009. Cardiovascular Disorders, dalam: Wells, B., DiPiro,

J., Schwinghammer, T., DiPiro, C. (Eds.), Pharmacotherapy Handbook,
Seventh Edition. McGraw Hill Professional.

Talley, N.J., Vakil, N.B., dan Moayyedi, P., 2005. American Gastroenterological
Association Technical Review on the Evaluation of Dyspepsia.
Gastroenterology, 129: 1756–1780.

Tatro, D.S. (Ed.), 2008. Drug Interaction Facts 2009: The Authority on Drug
Interactions, 1 edition. ed. Lippincott Williams & Wilkins, Saint Louis,
Mo.; London.

Tegegne, G.T., Belayneh Kefale Gelaw, Amsalu Degu Defersha, Elias, dan Elias
Ali Yesuf, 2014. Drug Therapy Problem Among Patients With

89
 Cardiovascular Diseases In Felege Hiwot Referral Hospital, North East,
Bahir Dar Ethiopia. Indo American Journal of Pharmaceutical Research,
4: 2828–2838.

Van Roozendaal, B.W. dan Krass, I., 2009. Development of an Evidence-Based

Checklist for the Detection of Drug Related Problems in Type 2 Diabetes.
Pharmacy World & Science, 31: 580–595.

Viktil, K.K., Blix, H.S., Moger, T.A., dan Reikvam, A., 2007. Polypharmacy as
commonly defined is an indicator of limited value in the assessment of
drug-related problems. British Journal of Clinical Pharmacology, 63:
187–195.

White, C.M., Song, J.C., dan Kalus, J.S., 2012. Cardiac Arrhythmias, dalam:
Alldredge, B.K., Corelli, R.L., Ernst, M.E. (Eds.), Koda-Kimble and
Young’s Applied Therapeutics: The Clinical Use of Drugs. Lippincott
Williams & Wilkins.

Widimsk, P., 2008. Hypokalemia and the Heart. European Society of Cardiology,
7: 9.

Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E., Drazner, M.H.,
dkk., 2013. 2013 ACCF/AHA Guideline for the Management of Heart
Failure A Report of the American College of Cardiology
Foundation/American Heart Association Task Force on Practice
Guidelines. Circulation, 128: e240–e327.

90